Tiverton Asset Management LLC trimmed its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 28.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,118 shares of the company’s stock after selling 17,500 shares during the period. Tiverton Asset Management LLC’s holdings in Colgate-Palmolive were worth $3,196,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. American Beacon Advisors Inc. acquired a new stake in Colgate-Palmolive during the 1st quarter valued at $102,000. Proficio Capital Partners LLC increased its holdings in Colgate-Palmolive by 16.9% during the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after purchasing an additional 207 shares in the last quarter. OLD Second National Bank of Aurora acquired a new stake in Colgate-Palmolive during the 2nd quarter valued at $109,000. Harbour Capital Advisors LLC acquired a new stake in Colgate-Palmolive during the 1st quarter valued at $121,000. Finally, Hanson & Doremus Investment Management increased its holdings in Colgate-Palmolive by 4.5% during the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after purchasing an additional 70 shares in the last quarter. 73.87% of the stock is owned by hedge funds and other institutional investors.
Colgate-Palmolive Company (CL) opened at $71.89 on Friday. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. The firm has a market capitalization of $63,780.00, a PE ratio of 25.60, a price-to-earnings-growth ratio of 3.36 and a beta of 0.80. Colgate-Palmolive Company has a twelve month low of $63.43 and a twelve month high of $77.27.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. The firm had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The company’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.73 earnings per share. equities analysts predict that Colgate-Palmolive Company will post 2.88 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd were issued a dividend of $0.40 per share. The ex-dividend date was Friday, October 20th. This represents a $1.60 annualized dividend and a yield of 2.23%. Colgate-Palmolive’s dividend payout ratio is presently 61.78%.
In other Colgate-Palmolive news, insider Victoria L. Dolan sold 9,000 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total transaction of $660,690.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CMO Mukul Deoras sold 7,500 shares of Colgate-Palmolive stock in a transaction dated Friday, November 10th. The stock was sold at an average price of $73.28, for a total value of $549,600.00. Following the transaction, the chief marketing officer now owns 45,217 shares in the company, valued at $3,313,501.76. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 173,673 shares of company stock worth $12,629,293. Corporate insiders own 1.02% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was reported by Transcript Daily and is the property of of Transcript Daily. If you are reading this report on another website, it was illegally stolen and republished in violation of U.S. & international copyright law. The correct version of this report can be read at https://transcriptdaily.com/2017/11/18/tiverton-asset-management-llc-sells-17500-shares-of-colgate-palmolive-company-cl.html.
CL has been the subject of a number of recent analyst reports. Zacks Investment Research cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Jefferies Group LLC reiterated a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Morgan Stanley decreased their price objective on Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 31st. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Finally, Macquarie began coverage on Colgate-Palmolive in a research report on Thursday, September 14th. They issued a “neutral” rating and a $76.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, fifteen have issued a hold rating and four have assigned a buy rating to the stock. Colgate-Palmolive presently has a consensus rating of “Hold” and an average price target of $76.67.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.